Quality of Life Following Radical Prostatectomy

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Stanford University
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
First received: September 6, 2006
Last updated: November 16, 2015
Last verified: November 2015
This study will utilize the Expanded Prostate Cancer Index Composite questionnaire to learn what impact the surgery has upon the participant's sense of health, sexual and urinary quality of life.

Prostatic Neoplasms
Prostate Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Quality of Life Following Radical Prostatectomy

Resource links provided by NLM:

Further study details as provided by Stanford University:

Primary Outcome Measures:
  • urinary and bowel habits [ Time Frame: before and after surgery ] [ Designated as safety issue: No ]
  • sexual and hormonal index as self-reported in the questionnaires [ Time Frame: before and after surgery ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: September 2002
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Detailed Description:
To define impact on quality of life issues for patients undergoing radical prostatectomy. This study will distribute a questionnaire to patients who are being scheduled for radical prostatectomy, both before and after surgery, to assess the impact on quality of life issues. This will provide important information regarding the temporal return of issues pertaining to quality of life.

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients scheduled to undergo radical prostatectomy at Stanford

Inclusion Criteria:

- Patients scheduled to undergo radical prostatectomy at Stanford

Exclusion Criteria:

- Patients treated with neoadjuvant or adjuvant hormonal therapy or radiation therapy

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00373308

United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Denise Haas    650-736-1252    dhaas@stanford.edu   
Principal Investigator: Benjamin I Chung         
Sub-Investigator: James D Brooks         
Sub-Investigator: Harcharan Gill         
Sub-Investigator: Mark Gonzalgo         
Sponsors and Collaborators
Stanford University
Principal Investigator: Benjamin I Chung Stanford University
  More Information

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT00373308     History of Changes
Other Study ID Numbers: PROS0012  78463  PROS0012 
Study First Received: September 6, 2006
Last Updated: November 16, 2015
Health Authority: United States: Institutional Review Board

Keywords provided by Stanford University:
Quality of Life

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms

ClinicalTrials.gov processed this record on May 26, 2016